机器人与腹腔镜胃癌淋巴结清扫术随机对照试验研究方案
本研究为单中心随机对照试验,计划纳入240例可手术切除的Ⅰ-Ⅲ期胃癌患者,比较机器人胃切除术与腹腔镜胃切除术的短期手术结局和长期肿瘤学结局。主要终点为术后腹腔感染性并发症(包括胰瘘、腹腔脓肿和吻合口漏)的发生率,次要终点包括任何并发症、手术结果、术后病程及肿瘤学结局。
要点
- 机器人胃切除术在胰周淋巴结清扫中可能降低腹腔感染性并发症。
- 试验计划纳入240例Ⅰ-Ⅲ期可切除胃癌患者。
- 主要终点为术后腹腔感染性并发症发生率。
核心结论
- 需前瞻性随机对照试验比较机器人胃切除术与腹腔镜胃切除术的短期手术和长期肿瘤学结局。
研究设计与样本
- 随机、单中心临床试验,纳入240例原发胃腺癌、肿瘤可手术切除(Ⅰ-Ⅲ期)的成人患者。
主要发现
- 既往回顾性研究中,腹腔镜胃切除术组腹腔感染性并发症发生率为11%,机器人胃切除术组未见发生。
- 腹腔镜胃切除术后胰瘘发生率约为4-7%。
关键数值与推荐
- 主要终点为术后腹腔感染性并发症发生率,包括胰瘘、腹腔脓肿和吻合口漏。
- 次要终点包括任何并发症(手术相关及非手术相关)发生率、手术结果、术后病程和肿瘤学结局。
临床怎么用
- 研究结果可能有助于减少机器人胃切除术的限制并推动其适应症扩展。
局限性
- 为单中心临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic gastrectomy (LG) has several benefits as a treatment of gastric cancer (GC), including reduced pain, early recovery of intestinal function, and shorter hospital stay. LG still has several drawbacks, however, including limited range of movement, amplification of hand tremors, and inconvenient surgical positioning. Around the peripancreatic area, laparoscopic lymph node dissection, therefore, remains challenging; postoperative pancreatic fistula occurs in around 4-7% of patients undergoing LG. Robotic surgery, on the other hand, plays a role in ergonomics and offers several advantages, including 7° of wrist-like motion, less fatigue, tremor filtering, motion scaling, and three-dimensional vision. In our previous retrospective study, we compared the safety and feasibility of surgical outcomes of LG and robotic gastrectomy (RG) for patients with GC. In our previous results, in the LG group, intra-abdominal infectious complications were found in 11%. In the RG group, however, none were found. Our RG procedure may be associated with decreased incidence of intra-abdominal infectious complications. Prospective randomized controlled trials (RCTs) comparing LG and RG are required, however. We begin an RCT to compare short-term surgical and long-term oncological outcomes of LG and RG for GC patients. METHODS: This is a randomized, single-center clinical trial. All included patients are adults with primary carcinoma of the stomach, in whom the tumor is considered surgically resectable (stages I-III). Included in this trial are 240 patients with GC. The primary endpoint is to assess the incidence of postoperative intra-abdominal infectious complications including pancreatic fistula, intra-abdominal abscess, and anastomotic leakage. Secondary endpoints include the incidence of any complications (both related and unrelated to surgery), surgical results, postoperative course, and oncological outcomes. DISCUSSION: Although its short-term outcomes have been proven comparable to LG in comparative studies, use of RG remains restricted, partly due to the lack of informative RCTs pertaining to it. To evaluate the surgical and oncological outcomes of RG, we therefore undertake a prospective RCT. The obtained results will be useful for reducing the restrictions and for adaptive expansion of RG for patients with GC. TRIAL REGISTRATION: University Hospital Medical Information Network Clinical Trials Registry, ID: UMIN000031536 . Registered on 1 March 2017.
引用
- Ojima T, Nakamura M, Nakamori M, et al. Robotic versus laparoscopic gastrectomy with lymph node dissection for gastric cancer: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30064474. doi:10.1186/s13063-018-2810-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。